AtriCure, Inc.
ATRC · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $465,307 | $399,245 | $330,379 | $274,329 |
| % Growth | 16.5% | 20.8% | 20.4% | – |
| Cost of Goods Sold | $117,783 | $98,875 | $84,439 | $68,469 |
| Gross Profit | $347,524 | $300,370 | $245,940 | $205,860 |
| % Margin | 74.7% | 75.2% | 74.4% | 75% |
| R&D Expenses | $96,178 | $73,915 | $57,337 | $48,506 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $291,359 | $253,138 | $231,272 | $204,649 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | -$102,500 |
| Operating Expenses | $387,537 | $327,053 | $288,609 | $150,655 |
| Operating Income | -$40,013 | -$26,683 | -$42,669 | $55,205 |
| % Margin | -8.6% | -6.7% | -12.9% | 20.1% |
| Other Income/Exp. Net | -$3,661 | -$3,164 | -$3,529 | -$4,818 |
| Pre-Tax Income | -$43,674 | -$29,847 | -$46,198 | $50,387 |
| Tax Expense | $1,024 | $591 | $268 | $188 |
| Net Income | -$44,698 | -$30,438 | -$46,466 | $50,199 |
| % Margin | -9.6% | -7.6% | -14.1% | 18.3% |
| EPS | -0.95 | -0.66 | -1.02 | 1.11 |
| % Growth | -43.9% | 35.3% | -191.9% | – |
| EPS Diluted | -0.95 | -0.66 | -1.02 | 1.09 |
| Weighted Avg Shares Out | 46,965 | 46,309 | 45,740 | 45,066 |
| Weighted Avg Shares Out Dil | 46,965 | 46,309 | 45,740 | 46,039 |
| Supplemental Information | – | – | – | – |
| Interest Income | $4,434 | $3,792 | $1,994 | $466 |
| Interest Expense | $6,407 | $6,925 | $4,986 | $4,918 |
| Depreciation & Amortization | $18,733 | $14,813 | $11,710 | $10,441 |
| EBITDA | -$18,534 | -$8,109 | -$29,502 | $65,746 |
| % Margin | -4% | -2% | -8.9% | 24% |